Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;93:1403-1410

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lembo, G.
Right arrow Articles by Trimarco, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lembo, G.
Right arrow Articles by Trimarco, B.

(Circulation. 1996;93:1403-1410.)
© 1996 American Heart Association, Inc.


Articles

Insulin Modulation of ß-Adrenergic Vasodilator Pathway in Human Forearm

Giuseppe Lembo, MD, PhD; Guido Iaccarino, MD; Carmine Vecchione, MD; Virgilio Rendina, MD; Lucia Parrella, PhD; Bruno Trimarco, MD

From the Istituto Neurologico Mediterraneo, Neuromed, Pozzilli (IS) (G.L., C.V., B.T.), and the Department of Internal Medicine, School of Medicine, Federico II University, Naples (G.I., V.R., L.P., B.T.), Italy.

Correspondence to Bruno Trimarco, MD, Medicina Interna, Università di Napoli Federico II, Via S Pansini 5, 80131 Napoli, Italy. E-mail trimarco@ds.cised.unina.it.

Background Insulin modulates sympathetic vasoconstriction, but the mechanisms underlying this effect are not completely elucidated. We have recently investigated the insulin effect on the {alpha}1- and {alpha}2-adrenergic vasoconstriction pathway, where it is still conflicting with the possible insulin influence on the ß-adrenergic vasodilator pathway. The aim of the present study was to investigate this issue.

Methods and Results The study was performed on the forearm of healthy humans, and all test substances were infused into the brachial artery at systemically ineffective rates. In five subjects, we evaluated isoproterenol-induced vasodilation (1, 3, 6, and 9 ng·kg-1·min-1) both under control conditions and during insulin infusion (0.05 mU·kg-1·min-1). In another group of five subjects, we tested whether the vasorelaxant effect of sodium nitroprusside (1, 2, 4, and 8 ng·kg-1·min-1) was modified by insulin. Moreover, to explore whether the interaction between insulin and forearm ß-adrenergic pathway participates in insulin modulation of sympathetic-evoked vasoconstriction, we measured in six normal subjects the forearm vascular response to lower-body negative pressure under control conditions and during intrabrachial infusion of insulin alone and in combination with a selective ß-adrenergic blocking agent (propranolol 10 µg/100 mL per minute). Finally, to verify whether insulin interaction with the ß-adrenergic pathway may also account for insulin modulation of {alpha}2-adrenergic vasoconstriction, we assessed the vascular response to a selective {alpha}2-adrenergic agonist before and after propranolol administration. Insulin exposure potentiated the vascular responsiveness to isoproterenol but did not affect the vasodilator response to sodium nitroprusside. Furthermore, the insulin-induced attenuation of sympathetic vasoconstriction was partially corrected by propranolol. In contrast, the insulin modulation of {alpha}2-adrenergic vasoconstriction was not influenced by ß-adrenergic blockade.

Conclusions Taken together, our results suggest that insulin modulation of sympathetic-induced vasoconstriction is carried out through an interaction of the hormone with the pathways of both {alpha}2- and ß-adrenergic receptors.


Key Words: forearm vascular resistance • nervous system • receptors, adrenergic, alpha




This article has been cited by other articles:


Home page
HypertensionHome page
G. de Simone, F. Pasanisi, and F. Contaldo
Link of Nonhemodynamic Factors to Hemodynamic Determinants of Left Ventricular Hypertrophy
Hypertension, July 1, 2001; 38(1): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Laine, M. J. Knuuti, U. Ruotsalainen, T. Utriainen, V. Oikonen, M. Raitakari, M. Luotolahti, O. Kirvela, P. Vicini, C. Cobelli, et al.
Preserved Relative Dispersion but Blunted Stimulation of Mean Flow, Absolute Dispersion, and Blood Volume by Insulin in Skeletal Muscle of Patients With Essential Hypertension
Circulation, June 2, 1998; 97(21): 2146 - 2153.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Scherrer and C. Sartori
Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity
Circulation, December 2, 1997; 96(11): 4104 - 4113.
[Abstract] [Full Text]